Jiao Li
No. 16 Jiangsu Road
Qingdao, 266003, China
Qingdao, 266003, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Construction and validation of a nomogram model for predicting response to initial radioiodine therapy in differentiated thyroid cancer patients using serum cytokines combined with serum thyroglobulin.
Journal: Frontiers in endocrinology
Published: February 03, 2026
Clinical outcome and influencing factors of differentiated thyroid cancer with biochemical incomplete response.
Journal: Future oncology (London, England)
Published: August 20, 2025
Clinical outcome and influencing factors of differentiated thyroid cancer patients with radioiodine-refractory lung metastasis.
Journal: Frontiers in endocrinology
Published: May 03, 2025
Clinical value of 99mTc-MIBI scintigraphy combined with posttherapeutic 131I whole-body scanning in patients with differentiated thyroid cancer with sTg ≥10 ng/mL before initial radioiodine therapy: a retrospective study.
Journal: Quantitative imaging in medicine and surgery
Published: March 06, 2025
Reflective analysis on the current 131I adjuvant therapy indications in intermediate- and high-risk differentiated thyroid cancer.
Journal: European journal of nuclear medicine and molecular imaging
Published: December 05, 2024
Prognostic factors in children and adolescents with differentiated thyroid cancer treated with total thyroidectomy and radioiodine therapy: a retrospective two-center study from China.
Journal: Frontiers in endocrinology
Published: April 17, 2024
Stimulated thyroglobulin and pre-ablation antithyroglobulin antibody products can predict the response to radioiodine therapy of TgAb-positive differentiated thyroid cancer patients: a retrospective study.
Journal: Frontiers in endocrinology
Published: May 14, 2023
Long-term prognostic analysis of children and adolescents with differentiated thyroid carcinoma based on therapeutic response to initial radioiodine therapy.
Journal: Frontiers in endocrinology
Published: May 04, 2023
Efficacy evaluation and influencing factor analysis of postoperative 131I for the treatment of primary hyperthyroidism combined with differentiated thyroid cancer (DTC)-a retrospective cohort study.
Journal: Gland surgery
Published: November 21, 2022
First Discovery of Cholesterol-Lowering Activity of Parthenolide as NPC1L1 Inhibitor.
Journal: Molecules (Basel, Switzerland)
Published: August 22, 2022
Last Updated: 09/26/2026